25.09.2014 - US-based Acorda Therapeutics has acquired privately held Civitas Therapeutics for $525 million to gain access to a Parkinson's disease drug in late-stage development. With the buy...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)